Status: Recruiting Double-blinded randomized clinical trial investigating the effects of subcutaneous semaglutide vs placebo on alcohol consumption in 108 patients diagnosed with alcohol use disorder and comorbid obesity over a 26-week period
While peptides provide the cellular instructions for repair and regeneration, IV nutrients deliver the raw materials your cells need to follow those instructions effectively
Secondly, to that point, is that people are looking at this potentially as a short-term solution
GLP-1 medications have transformed obesity treatment by helping people lose significant amounts of weight and improve conditions like type 2 diabetes, prediabetes, PCOS, fatty liver disease, high cholesterol, and high blood pressure
Long-term trials confirm it can still deliver meaningful and sustainable benefits for many patients